Straumann, a global leader in replacement, restorative and regenerative dentistry, has signed an agreement to acquire 44% of Valoc AG, a privately-held Swiss company founded in 2011 that develops and manufactures innovative retention systems for removable implant-borne dentures. Financial terms were not disclosed.
One of the most popular modern treatment options for edentulous patients is to use dental implants to anchor a removable denture. The retention devices that attach the denture to the implant connection are sophisticated and precise, holding the denture firmly in place but also allowing it to be removed and replaced easily for cleaning.
Valoc’s Swiss-made Novaloc is a highly durable, precise, flexible and innovative attachment system, which is compatible with most leading dental implant systems. Its Optiloc range, which is currently in development, will be one of the smallest overdenture attachment systems on the market, offering high durability and user-friendliness. Although Valoc is a young, growing company, its products have already become established in Germany and other central European markets, thanks to the fact that Medentika is their main distributor.
Straumann is the ideal partner for Valoc, offering global reach and roll-out experience, along with access to both the premium and value segments. Valoc offers the latest material technology, innovative designs which are market-proven, and an exciting development pipeline.
About Valoc
Founded in 2011, Valoc AG is a privately-held Swiss company based in Möhlin and specialized in overdenture-attachment systems for multiple dental implant systems. Its leading product is the Novaloc system, which uses the latest materials for high durability and a patented method for exchanging retention inserts. Valoc’s products are currently available in most European countries through various distributors. For more information, please visit www.valoc.ch.
About Straumann
Headquartered in Basel, Switzerland, Straumann is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately 2400 people worldwide and its products and services are available in more than 70 countries through its broad network of distribution subsidiaries and partners.
0Comments
Please login or sign up to comment.
Commenting guidelines